| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...623629Z |
| P356 | DOI | 10.1371/JOURNAL.PONE.0023629 |
| P932 | PMC publication ID | 3163640 |
| P698 | PubMed publication ID | 21897850 |
| P5875 | ResearchGate publication ID | 51625037 |
| P50 | author | Julie Wang | Q89552243 |
| P2093 | author name string | Xiaohui Zhou | |
| Zhongmin Liu | |||
| Zanxian Xia | |||
| William Stohl | |||
| Wenru Su | |||
| Huimin Fan | |||
| Yuan-Ping Han | |||
| Song Guo Zheng | |||
| Qin Lan | |||
| P2860 | cites work | BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth | Q22009942 |
| TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease | Q22254041 | ||
| The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed | Q24311586 | ||
| NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily | Q24314630 | ||
| BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma | Q24646563 | ||
| BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2 | Q27639845 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator | Q28139180 | ||
| Characterization of a new member of the TNF family expressed on antigen presenting cells | Q28144198 | ||
| Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency | Q28190857 | ||
| BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF | Q28213294 | ||
| DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL | Q28216755 | ||
| STAT3 regulates cytokine-mediated generation of inflammatory helper T cells | Q28286840 | ||
| Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial | Q28304807 | ||
| B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells | Q28590517 | ||
| Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis | Q30484091 | ||
| Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus | Q33928629 | ||
| Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. | Q33951524 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway | Q57230082 | ||
| Synthesis and release of B-lymphocyte stimulator from myeloid cells | Q73335981 | ||
| TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice | Q74108088 | ||
| TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS | Q74419758 | ||
| BAFF is a survival and maturation factor for mouse B cells | Q74456240 | ||
| Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice | Q79317500 | ||
| IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis | Q79755041 | ||
| Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis | Q80340621 | ||
| Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes | Q82132578 | ||
| Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot | Q33999367 | ||
| Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome | Q34108411 | ||
| Similarities and differences between selective and nonselective BAFF blockade in murine SLE | Q34350295 | ||
| Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus | Q34802966 | ||
| Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells | Q34927437 | ||
| Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. | Q34994485 | ||
| Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice | Q35110335 | ||
| BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population | Q35834649 | ||
| Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. | Q36229199 | ||
| Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response | Q36368953 | ||
| Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations | Q36375661 | ||
| TACI and BAFF-R mediate isotype switching in B cells | Q36402479 | ||
| Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity | Q36983608 | ||
| B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation | Q37009908 | ||
| IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice | Q37036086 | ||
| A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus | Q37378350 | ||
| Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy | Q40272900 | ||
| G-CSF-stimulated neutrophils are a prominent source of functional BLyS | Q41818295 | ||
| Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells | Q42079747 | ||
| A role for BLyS in the activation of innate immune cells | Q42742005 | ||
| In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis | Q42876667 | ||
| BAFF mediates survival of peripheral immature B lymphocytes | Q42944182 | ||
| The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome | Q43050637 | ||
| Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis | Q43208021 | ||
| T cell costimulation by the TNF ligand BAFF. | Q43803679 | ||
| A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses | Q45302161 | ||
| Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. | Q45998381 | ||
| B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. | Q46001110 | ||
| Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis | Q47274470 | ||
| BAFF augments certain Th1-associated inflammatory responses. | Q47810975 | ||
| B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization | Q48364459 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | e23629 | |
| P577 | publication date | 2011-08-29 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis | |
| P478 | volume | 6 |
| Q52885446 | A Novel BLyS Peptibody Down-Regulates B Cell and T Helper Cell Subsets In Vivo and Ameliorates Collagen-Induced Arthritis. |
| Q38961202 | B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. |
| Q46733493 | B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata |
| Q48195816 | BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis. |
| Q38006643 | Biologic differences between various inhibitors of the BLyS/BAFF pathway: should we expect differences between belimumab and other inhibitors in development? |
| Q36260857 | Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice |
| Q34365880 | Clinical associations of serum interleukin-17 in systemic lupus erythematosus |
| Q36762882 | Clinical targeting of the TNF and TNFR superfamilies |
| Q27026048 | Genetic requirements for the development and differentiation of interleukin-17-producing γδ T cells |
| Q92259788 | Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion |
| Q36421539 | Hematopoietic stem and multipotent progenitor cells produce IL-17, IL-21 and other cytokines in response to TLR signals associated with late apoptotic products and augment memory Th17 and Tc17 cells in the bone marrow of normal and lupus mice |
| Q34785104 | Human megakaryocyte progenitors derived from hematopoietic stem cells of normal individuals are MHC class II-expressing professional APC that enhance Th17 and Th1/Th17 responses |
| Q38861682 | Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations |
| Q37737549 | Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases |
| Q91711842 | Nuclear Factor κB (NF-κB)-Mediated Inflammation in Multiple Sclerosis |
| Q37590759 | Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells |
| Q26849719 | Profile of atacicept and its potential in the treatment of systemic lupus erythematosus |
| Q26800155 | Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity |
| Q26798209 | Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies |
| Q51108455 | TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus. |
| Q38765404 | Th17 cells in neuromyelitis optica spectrum disorder: a review |
| Q35691272 | The discovery and development of belimumab: the anti-BLyS-lupus connection |
| Q33748041 | The function of BAFF on T helper cells in autoimmunity |
| Q92302527 | The role of B cells in multiple sclerosis: Current and future therapies |
| Q38187489 | Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus |
| Q35986113 | Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials. |
| Q44219240 | VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. |
Search more.